Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics.

Tiro JA, Pruitt SL, Bruce CM, Persaud D, Lau M, Vernon SW, Morrow J, Skinner CS.

Vaccine. 2012 Mar 16;30(13):2368-75. doi: 10.1016/j.vaccine.2011.11.031. Epub 2011 Nov 21.

PMID:
22108490
2.

Race, ethnicity, and income factors impacting human papillomavirus vaccination rates.

Jeudin P, Liveright E, Del Carmen MG, Perkins RB.

Clin Ther. 2014 Jan 1;36(1):24-37. doi: 10.1016/j.clinthera.2013.11.001. Review.

PMID:
24417783
3.

Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis.

Fisher H, Trotter CL, Audrey S, MacDonald-Wallis K, Hickman M.

Int J Epidemiol. 2013 Jun;42(3):896-908. doi: 10.1093/ije/dyt049. Epub 2013 Apr 25. Review.

4.

Race, ethnicity and income as factors for HPV vaccine acceptance and use.

Jeudin P, Liveright E, del Carmen MG, Perkins RB.

Hum Vaccin Immunother. 2013 Jul;9(7):1413-20. doi: 10.4161/hv.24422. Epub 2013 Apr 9. Review.

PMID:
23571170
5.

Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.

Poljak M.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:64-9. doi: 10.1111/j.1469-0691.2012.03946.x. Epub 2012 Aug 6. Review.

6.

Factors associated with HPV vaccine uptake in teenage girls: a systematic review.

Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL.

Vaccine. 2012 May 21;30(24):3546-56. doi: 10.1016/j.vaccine.2012.03.063. Epub 2012 Apr 3. Review.

PMID:
22480928
8.

Human papillomavirus vaccine in adolescent women: a 2012 update.

Etter DJ, Zimet GD, Rickert VI.

Curr Opin Obstet Gynecol. 2012 Oct;24(5):305-10. doi: 10.1097/GCO.0b013e3283567005. Review.

PMID:
22781077
9.

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.

Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JM, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, Kahn JA, Kavanagh K, Kjaer SK, Kliewer EV, Lemieux-Mellouki P, Markowitz L, Mboup A, Mesher D, Niccolai L, Oliphant J, Pollock KG, Soldan K, Sonnenberg P, Tabrizi SN, Tanton C, Brisson M.

Lancet Infect Dis. 2015 May;15(5):565-80. doi: 10.1016/S1473-3099(14)71073-4. Epub 2015 Mar 3. Review.

10.

Human Papillomavirus Infection and Vaccination.

Valentino K, Poronsky CB.

J Pediatr Nurs. 2016 Mar-Apr;31(2):e155-66. doi: 10.1016/j.pedn.2015.10.005. Epub 2015 Nov 14. Review.

PMID:
26586310
11.

Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.

Vetter KM, Geller SE.

J Womens Health (Larchmt). 2007 Nov;16(9):1258-68. Review.

PMID:
18001182
12.

Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.

Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA.

Pharmacotherapy. 2011 Mar;31(3):280-97. doi: 10.1592/phco.31.3.280. Review.

PMID:
21361739
13.

Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.

Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S.

JAMA Pediatr. 2014 Jan;168(1):76-82. doi: 10.1001/jamapediatrics.2013.2752. Review.

14.

The future of cervical cancer prevention: human papillomavirus vaccines.

Cadman L.

J Fam Health Care. 2008;18(4):131-2. Review.

PMID:
18754553

Supplemental Content

Support Center